A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer

BACKGROUND: Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patients with stages I and II non-small cell lung cancer (NSCLC) will die from recurrent disease despite surgical resection. No reliable clinical or molecular predictors are currently available f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yan, Lemon, William, Liu, Peng-Yuan, Yi, Yijun, Morrison, Carl, Yang, Ping, Sun, Zhifu, Szoke, Janos, Gerald, William L, Watson, Mark, Govindan, Ramaswamy, You, Ming
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716187/
https://www.ncbi.nlm.nih.gov/pubmed/17194181
http://dx.doi.org/10.1371/journal.pmed.0030467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716187/
https://www.ncbi.nlm.nih.gov/pubmed/17194181
http://dx.doi.org/10.1371/journal.pmed.0030467

Ejemplares similares